drugset
Drugs / bitter melon
last change Dec 2022 re-read 2 minutes ago

bitter melon

also known as Momordica charantia · Momordica charantia extract
Developed for
Plasmodium falciparum malaria
Investigated by
Apt. Dian Yudianto; Dr. dr Erni J. Nelwan, Sp.PD, Ph.D; Apt.Hesty Utami Ramadaniati, M.Clin, Pharm, Ph.D · Syamsudin Abdillah,Ph.D, Pharm D

Trials 1 · a red edge is where a trial was stopped

today NCT05829187 · Ph 2
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05829187 Nov → Dec 2022 Plasmodium falciparum malaria Syamsudin Abdillah,Ph.D, Pharm D Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as bitter melon “extract of bitter melon (Momordica charantia/MC) regimens” NCT05829187 ↗
Known as Momordica charantia “extract of bitter melon (Momordica charantia/MC) regimens” NCT05829187 ↗
Known as Momordica charantia extract ClinicalTrials.gov intervention name — accepted as the source's own label NCT05829187 ↗